FDA approves Signos glucose monitoring for weight loss
Woman with Signos wearable and app Source: Signos The Food and Drug Administration on Wednesday approved the first-ever…
Meta shares fall on AI restructuring report, while Lilly shrugs off Novo’s Ozempic price move
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Eli Lilly and health-care stocks are week’s big winners, 3 sectors fell
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
‘Don’t quit the market’ when it’s frothy, says Jim Cramer. Here’s why
CNBC’s Jim Cramer on Thursday said that although the market may be frothy, investors shouldn’t quit because there…
An unusual suspect is leading Wednesday’s market while the AI trade takes a breather
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Jim Cramer’s top 10 things to watch in the stock market Wednesday
My top 10 things to watch Wednesday, Aug. 13 1. AI computing provider CoreWeave’s quarterly results were good,…
Eli Lilly obesity pill orforglipron led to 12% weight loss
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
Trump says pharma tariffs could eventually reach up to 250%
U.S. President Donald Trump talks to members of the press at Lehigh Valley International Airport in Allentown, Pennsylvania,…
Here are the 6 big things we’re watching in the market this week
Wall Street ended a busy week of earnings, economic data and policy decisions with a thud, as a…
How this week’s avalanche of news kept markets and investors guessing
It was a dizzying week on Wall Street. The S & P 500 closed this past Monday at…